Last reviewed · How we verify

NCT07201883

Chewing Gum vs. Ondansetron as Rescue Treatment for PONV in Female Patients

Active, enrolled Phase 1 Last updated 1 October 2025
What this trial tests

Phase 1 trial testing Ondansetron (Zofran) in Postoperative Nausea and Vomiting (PONV) in 90 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline
22 August 2025
Primary endpoint
28 February 2026
28 February 2026

Quick facts

Lead sponsorMakassed General Hospital
PhasePhase 1
StatusActive, enrolled
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment90
Start date22 August 2025
Primary completion28 February 2026
Estimated completion28 February 2026
Sites1 location across Lebanon

Drugs / interventions tested

Conditions studied

Sponsor

Makassed General Hospital

Who can join

18 and older, female only, with Postoperative Nausea and Vomiting (PONV). Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The proposed randomized clinical trial aims to test and compare the efficacy of chewing gum vs. Intravenous antiemetic ondansetron as rescue treatment for post-operative nausea and vomiting (PONV) among Lebanese female patients undergoing laparoscopic surgery in the post-operative anesthesia care unit (PACU).

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Ondansetron (Zofran)

Trials testing the same drug.

Other recruiting trials for Postoperative Nausea and Vomiting (PONV)

Currently open trials in the same condition.

Other Makassed General Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07201883.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing